BHARAT BIOTECH
COVID-19 Vaccine Covaxin True Example of Public-Private Partnership, Says ICMR Director General Balram Bhargava
Bharat Biotech's COVID-19 Vaccine Covaxin 77.8% Effective Against Coronavirus, Says Lancet Study
Covaxin Phase 3 Trial Update: Bharat Biotech's COVID-19 Vaccine Data Shows 77% Efficacy, Says Lancent
UK To Add India’s COVID-19 Vaccine Covaxin to Approved List From November 22, No Quarantine For Fully Vaccinated Travellers
Covaxin Latest Update: Bharat Biotech's Partner Ocugen Seeks Approval of COVID-19 Vaccine in America for Children Below 18 Years
Ocugen, Bharat Biotech's Partner, Asks US Authorities to Approve Emergency Use Authorisation for Covaxin for Children Below 18
WHO Panel Recommends Emergency Use Listing Status for Bharat Biotech’s COVID-19 Vaccine ‘COVAXIN’
Bharat Biotech's Covaxin May Get WHO's Emergency Use Approval Today; Here is A List Of Countries Where It is Approved
Australia Adds Bharat Biotech's Covaxin to Its List of Accepted Vaccines For Travellers
Covaxin, Bharat Biotech's COVID-19 Vaccine, Recognised by Australia for Establishing Traveller's Vaccination Status
Google Trends